BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31595628)

  • 1. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
    Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants.
    Lin A; Rodriguez FJ; Karajannis MA; Williams SC; Legault G; Zagzag D; Burger PC; Allen JC; Eberhart CG; Bar EE
    J Neuropathol Exp Neurol; 2012 Jan; 71(1):66-72. PubMed ID: 22157620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
    Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
    Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel fusion genes and chimeric transcripts in ependymal tumors.
    Olsen TK; Panagopoulos I; Gorunova L; Micci F; Andersen K; Kilen Andersen H; Meling TR; Due-Tønnessen B; Scheie D; Heim S; Brandal P
    Genes Chromosomes Cancer; 2016 Dec; 55(12):944-953. PubMed ID: 27401149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
    Olsen TK; Panagopoulos I; Meling TR; Micci F; Gorunova L; Thorsen J; Due-Tønnessen B; Scheie D; Lund-Iversen M; Krossnes B; Saxhaug C; Heim S; Brandal P
    Neuro Oncol; 2015 Oct; 17(10):1365-73. PubMed ID: 25795305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma.
    Lehman NL
    J Neurooncol; 2023 Feb; 161(3):425-439. PubMed ID: 36604386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
    Bogumil H; Sill M; Schrimpf D; Ismer B; Blume C; Rahmanzade R; Hinz F; Cherkezov A; Banan R; Friedel D; Reuss DE; Selt F; Ecker J; Milde T; Pajtler KW; Schittenhelm J; Hench J; Frank S; Boldt HB; Kristensen BW; Scheie D; Melchior LC; Olesen V; Sehested A; Boué DR; Abdullaev Z; Satgunaseelan L; Kurth I; Seidlitz A; White CL; Ng HK; Shi ZF; Haberler C; Deckert M; Timmer M; Goldbrunner R; Tauziède-Espariat A; Varlet P; Brandner S; Alexandrescu S; Snuderl M; Aldape K; Korshunov A; Witt O; Herold-Mende C; Unterberg A; Wick W; Pfister SM; von Deimling A; Jones DTW; Sahm F; Sievers P
    Acta Neuropathol; 2023 May; 145(5):667-680. PubMed ID: 36933012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
    Cacciotti C; Fleming A; Ramaswamy V
    J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric thalamic tumors in the MRI era: a Canadian perspective.
    Steinbok P; Gopalakrishnan CV; Hengel AR; Vitali AM; Poskitt K; Hawkins C; Drake J; Lamberti-Pasculli M; Ajani O; Hader W; Mehta V; McNeely PD; McDonald PJ; Ranger A; Vassilyadi M; Atkinson J; Ryall S; Eisenstat DD; Hukin J
    Childs Nerv Syst; 2016 Feb; 32(2):269-80. PubMed ID: 26597682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma.
    Tauziède-Espariat A; Beccaria K; Dangouloff-Ros V; Sievers P; Meurgey A; Pissaloux D; Appay R; Saffroy R; Grill J; Mariet C; Bourdeaut F; Hasty L; Métais A; Chrétien F; Blauwblomme T; Puget S; Boddaert N; Varlet P;
    Brain Pathol; 2023 Sep; 33(5):e13182. PubMed ID: 37349135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
    Hou Y; Pinheiro J; Sahm F; Reuss DE; Schrimpf D; Stichel D; Casalini B; Koelsche C; Sievers P; Wefers AK; Reinhardt A; Ebrahimi A; Fernández-Klett F; Pusch S; Meier J; Schweizer L; Paulus W; Prinz M; Hartmann C; Plate KH; Reifenberger G; Pietsch T; Varlet P; Pagès M; Schüller U; Scheie D; de Stricker K; Frank S; Hench J; Pollo B; Brandner S; Unterberg A; Pfister SM; Jones DTW; Korshunov A; Wick W; Capper D; Blümcke I; von Deimling A; Bertero L
    Acta Neuropathol; 2019 May; 137(5):837-846. PubMed ID: 30759284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
    Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
    Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
    Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioneuronal tumours with features of rosette-forming glioneuronal tumours of the fourth ventricle and dysembryoplastic neuroepithelial tumours: a report of three cases.
    Chen SY; Wang W; Wang LM; Lin QT; Zhao GG; Xu G; Lu DH; Piao YS
    Histopathology; 2016 Feb; 68(3):378-87. PubMed ID: 26040650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::MET fusion.
    Chapman N; Greenwald J; Suddock J; Xu D; Markowitz A; Humphrey M; Cotter JA; Krieger MD; Hawes D; Ji J
    Acta Neuropathol Commun; 2024 Apr; 12(1):63. PubMed ID: 38650040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
    Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
    Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.
    Pages M; Lacroix L; Tauziede-Espariat A; Castel D; Daudigeos-Dubus E; Ridola V; Gilles S; Fina F; Andreiuolo F; Polivka M; Lechapt-Zalcman E; Puget S; Boddaert N; Liu XQ; Bridge JA; Grill J; Chretien F; Varlet P
    Acta Neuropathol Commun; 2015 Dec; 3():85. PubMed ID: 26671581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYB/MYBL1::QKI fusion-positive diffuse glioma.
    Suh YY; Lee K; Shim YM; Phi JH; Park CK; Kim SK; Choi SH; Yun H; Park SH
    J Neuropathol Exp Neurol; 2023 Feb; 82(3):250-260. PubMed ID: 36592415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.